206 related articles for article (PubMed ID: 12763610)
1. Rapid reduction of ATP synthesis and lack of free radical formation by MPP+ in rat brain synaptosomes and mitochondria.
Fonck C; Baudry M
Brain Res; 2003 Jun; 975(1-2):214-21. PubMed ID: 12763610
[TBL] [Abstract][Full Text] [Related]
2. Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes.
Bougria M; Vitorica J; Cano J; Machado A
Eur J Pharmacol; 1995 Nov; 291(3):407-15. PubMed ID: 8719427
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
4. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
Fonck C; Baudry M
Brain Res; 2001 Jun; 905(1-2):199-206. PubMed ID: 11423095
[TBL] [Abstract][Full Text] [Related]
5. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
Chiba K; Trevor AJ; Castagnoli N
Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
Shen RS; Abell CW; Gessner W; Brossi A
FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes.
Maragos WF; Zhu J; Chesnut MD; Dwoskin LP
Biochem Pharmacol; 2002 Apr; 63(8):1499-505. PubMed ID: 11996892
[TBL] [Abstract][Full Text] [Related]
8. Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.
Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Miele M; De Natale G; Miele E
Neurosci Lett; 1993 Oct; 161(2):121-3. PubMed ID: 7903798
[TBL] [Abstract][Full Text] [Related]
9. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes.
Scotcher KP; Irwin I; DeLanney LE; Langston JW; Di Monte D
J Neurochem; 1990 Apr; 54(4):1295-301. PubMed ID: 2313288
[TBL] [Abstract][Full Text] [Related]
10. A new in vitro approach for investigating the MPTP effect on DA uptake.
Barc S; Page G; Fauconneau B; Barrier L; Huguet F
Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
[TBL] [Abstract][Full Text] [Related]
11. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
[TBL] [Abstract][Full Text] [Related]
12. Uptake of 1-methyl-4-phenylpyridinium ion (MPP+) and ATP content in synaptosomes.
Matsunaga M; Shirane Y; Aiuchi T; Nakamura Y; Nakaya K
Biol Pharm Bull; 1996 Jan; 19(1):29-33. PubMed ID: 8820906
[TBL] [Abstract][Full Text] [Related]
13. Paraquat neurotoxicity is distinct from that of MPTP and rotenone.
Richardson JR; Quan Y; Sherer TB; Greenamyre JT; Miller GW
Toxicol Sci; 2005 Nov; 88(1):193-201. PubMed ID: 16141438
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
Sershen H; Mason MF; Debler EA; Lajtha A
Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
[TBL] [Abstract][Full Text] [Related]
15. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
Danias P; Nicklas WJ; Ofori S; Shen J; Mytilineou C
J Neurochem; 1989 Oct; 53(4):1149-55. PubMed ID: 2788714
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10.
Moon Y; Lee KH; Park JH; Geum D; Kim K
J Neurochem; 2005 Jun; 93(5):1199-208. PubMed ID: 15934940
[TBL] [Abstract][Full Text] [Related]
17. Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP.
Arora PK; Riachi NJ; Fiedler GC; Singh MP; Abdallah F; Harik SI; Sayre LM
Life Sci; 1990; 46(5):379-90. PubMed ID: 2304377
[TBL] [Abstract][Full Text] [Related]
18. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
19. Glutamate-induced free radical formation in rat brain synaptosomes is not dependent on intrasynaptosomal mitochondria membrane potential.
Alekseenko AV; Lemeshchenko VV; Pekun TG; Waseem TV; Fedorovich SV
Neurosci Lett; 2012 Apr; 513(2):238-42. PubMed ID: 22387155
[TBL] [Abstract][Full Text] [Related]
20. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.
Heikkila RE; Hwang J; Ofori S; Geller HM; Nicklas WJ
J Neurochem; 1990 Mar; 54(3):743-50. PubMed ID: 2303810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
